NeuroTrauma Sciences
Phase 1Scot Barry, MS joined NeuroTrauma Sciences in July 2021 as Vice President of Chemistry, Manufacturing and Controls (CMC) before moving to his current role as President. Scot brings operational expertise in small molecule commercialization to the organization through his knowledge of chemical development, outsourcing/partnering management as well as regulatory and intellectual property strategy. With more than 30 years in the CDMO and biopharmaceutical industry, he has provided technical and s...
About
Scot Barry, MS joined NeuroTrauma Sciences in July 2021 as Vice President of Chemistry, Manufacturing and Controls (CMC) before moving to his current role as President. Scot brings operational expertise in small molecule commercialization to the organization through his knowledge of chemical development, outsourcing/partnering management as well as regulatory and intellectual property strategy. With more than 30 years in the CDMO and biopharmaceutical industry, he has provided technical and s...
Funding History
2Total raised: $30M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile